Skip to content
naulon
Not checkedNot checked for notices yet.

Luciferase assay system to monitor fibroblast growth factor signal disruption in human iPSCs

Seiya Kanno, Kashu Mizota, Yusuke Okubo and 3 more

STAR Protocols · 2022

doi:10.1016/j.xpro.2022.101439 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Summary: We describe a protocol for a live-cell luciferase assay system for continuously monitoring fibroblast growth factor (FGF) signal disruption in human-induced pluripotent stem cells (iPSCs). Signal disrupting effects of chemicals are used as an indicator to evaluate toxicity. The assay is reliably predictive of the effects of limb malformation chemicals (AUC = 0.93). The current approach is limited to FGF signal disruption, and combinations with other types of signaling will be required to detect the effects of different toxicants.For complete details on the use and execution of this protocol, please refer to Kanno et al. (2022a).: Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.